Patent · US Active

Proton-binding polymers for oral administration

US11738041B2 · kind B2 · utility

0Cited by

50References

10Claims

0Family size

Assignee

Renosis, Inc. · US

Inventors

Gerrit Klaerner · Los Gatos, US
Eric Connor · Los Gatos, US
Randi K. GBUR · Brisbane, US
Matthew J. KADE · Berkeley, US
Paul H. KIERSTEAD · Oakland, US
Jerry M. Buysse · Los Altos, US
Michael J. Cope · Berkeley, US
Kalpesh Biyani · Fremont, US
Son H. NGUYEN · Milpitas, US
Scott M. TABAKMAN · Palo Alto, US

Key dates

Filing date	Apr 19, 2022
Grant date	Aug 29, 2023
Priority date	—
Expiry date	Apr 19, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC08F226/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions for and methods of treating an animal, including a human, and methods of preparing such compositions. The pharmaceutical compositions contain crosslinked amine polymers and may be used, for example, to treat diseases or other metabolic conditions in which removal of protons and/or chloride ions from the gastrointestinal tract would provide physiological benefits such as normalizing serum bicarbonate concentrations and the blood pH in an animal, including a human.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.